Skip to main content
SpringerLink
Log in

Cardiovascular (CV) risk control, particularly aspirin use, is not up to scratch in diabetes patients.

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Shrivastava R, Khan A, Jeevanantham V, Nautiyal A, Garg P, Reddy PC.Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive. Southern Medical Journal 101: 606-611, No. 6, Jun 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cardiovascular (CV) risk control, particularly aspirin use, is not up to scratch in diabetes patients.. Pharmacoecon. Outcomes News 558, 8 (2008). https://doi.org/10.2165/00151234-200805580-00022

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805580-00022

Keywords

Search

Navigation